An interventional study of Diabetes Prevention Program and Breastfeeding in Overweight or Obesity and Pregnancy, sponsored by University of Kansas Medical Center. Completed at 1 site in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by University of Kansas Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Obesity by University of Kansas Medical Center — 9 open to participants now, 9 under way, none of them phase 3. Obesity · University of Kansas Medical Center.
Among the 32 studies in Obesity by University of Kansas Medical Center, this one is the 16th largest by enrollment of the 29 interventional ones that give a count, is one of 5 that started in 2024, is one of 28 with no phase, and was the 24th registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →9 of the 32 studies in Obesity by University of Kansas Medical Center are open now, in 1 country. Recruiting first, the newest first:
University of Kansas Medical Center · Sites in United States
Ages 18–64
University of Kansas Medical Center · Sites in United States
Ages 18–45 · Women only · Healthy volunteers
University of Kansas Medical Center · Sites in United States
Ages 18–35
University of Kansas Medical Center · Sites in United States
Ages 18+
University of Kansas Medical Center · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 43 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 60 across the 29 interventional studies, 60 across the 3 observational. Of the 22 that completed or were terminated, 9 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Kansas Medical Center is the lead sponsor of 493 studies on the registry; 111 are open to participants now.
Of its 38 completed or terminated interventional studies of FDA-regulated products, 24 (63%) have results posted.
2 of the studies in Obesity by University of Kansas Medical Center that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06640179University of Kansas Medical CenterFeasibility and Plausible Effectiveness of a Lifestyle Intervention in Kidney Transplant Recipients (HEAL) | 2027-02-01 |
| NCT05985486University of Kansas Medical CenterBrain Outcomes With Lifestyle Change in Down Syndrome | 2027-09-30 |
Add all 2 to your calendar (.ics) → With an account.
Among the 32 studies in Obesity by University of Kansas Medical Center, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to investigate the impact of a comprehensive intervention that combines breastfeeding support with a diabetes prevention-based program (DPP) on postpartum weight retention and lactation duration among women with pre-pregnancy overweight or obesity. This intervention, named eMOMS, is delivered by a certified health coach via a mobile health (mHealth) application.
This study is a randomized controlled trial designed to determine the feasibility and efficacy of a combined breastfeeding, diabetes prevention-based program (DPP) in a cohort of overweight or obese women to be followed during pregnancy through 3 months postpartum. The trial will have two study arms: DPP + breastfeeding (Tx1) and Usual Care (Tx2).
Aim 1: Measure weight loss and duration of lactation through 3 months postpartum among target population. To accomplish this, we will measure pre-pregnancy weight, weight at study entry, weight immediately prior to and after delivery, and weight at specific postpartum time points. Lactation and infant feeding practices will be measured at similar postpartum time points. Aim 2: Quantify interest in use of the DPP-lactation mobile health (mHealth) application among target population. To accomplish this, we will: (1) measure research engagement including rates of screening and recruitment among users, especially rural and racially/ethnically diverse women; and (2) evaluate intervention uptake, delivery, and adherence via tracking/measuring use of the mHealth app.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
This study's enrollment of 43 is below the median of 67 across 9,043 interventional studies indexed under Obesity.
Browse Obesity studies →University of Kansas Medical Center is the lead sponsor of 493 studies on the registry; 111 are open to participants now.
Of its 38 completed or terminated interventional studies of FDA-regulated products, 24 (63%) have results posted.
Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients randomized to Tx1 will receive education in the Diabetes Prevention Program (DPP) and intensive breastfeeding education and support. Ante- and postpartum education includes access to the mHealth app and individualized 1-on-1 health coaching. Phase I is delivered antepartum and includes: four (4) 1-hour DPP-based educational sessions and six (6) 20-minute educational videos on lactation. Phase II is delivered postpartum and includes: in-hospital lactation support and two (2) 1-hour DPP-based educational sessions. Participants will continue to receive individualized 1-on-1 health coaching through 3 months postpartum.
Behavioral: Diabetes Prevention Program · Behavioral: Breastfeeding · Behavioral: Usual Care
Usual care is described as obstetrical care that pregnant women with normal BMI receive and that is provided by their provider. There will not be any antepartum education or 1-on-1 health coaching. Postpartum education will only include usual care in-hospital lactation support. There will not be any other education nor 1-on-1 support.
Behavioral: Usual Care
The intervention will be administered by professionally trained, certified health coaches. Phase I consists of four 1-hour DPP-based sessions to be completed during pregnancy. Each session will be pre-recorded and archived on a secure, private mHealth application. Participants will be asked to complete each session on their own time. A health coach will follow up weekly via phone to check on progress and will work with the participant 1-on-1, if needed. Phase I will be completed by week 36 of pregnancy. Prior to delivery, participants are invited to a virtual focus group about their experiences. Phase II consists of two 1-hour DPP-based sessions to be completed after delivery. Each session will be pre-recorded and archived on the same mHealth application. Participants will begin Phase II within 1 week of delivery with the same health coach. Phase II will be completed by week 12 postpartum. Upon completion, participants are invited to a virtual focus group about their experiences.
Phase I also consists of six (6) breastfeeding videos that are pre-recorded into 15-20 minute sessions and will be available on the mHealth application. Participants will have access to the first 2 sessions by week 28 of pregnancy and need to complete the remaining 4 sessions by week 36 of pregnancy. Each session is taught by an International Board Certified Lactation Consultant (IBCLC). Participants will receive 1-on-1 lactation support by the same DPP health coach. The health coach is a professionally trained Certified Breastfeeding Specialist (CBS). She will assist participants with any questions related to lactation. If the health coach is unable to help with a specific issue, she will contact the IBCLC-of-record, who will provide assistance to the health coach only. If the health coach or IBCLC deems additional care necessary, the participant will be referred to their primary care physician. The IBCLC will not have direct contact with the study participants.
Participants will receive regular prenatal care provided by their physician. At delivery, all participants will receive some type of lactation support in the hospital.
Change in Weight
The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms.
Time frame: At baseline and at delivery through 3 months postpartum
Maternal Weight
The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms.
Time frame: At baseline and at delivery through 3 months postpartum
Duration of Breastfeeding and Supplementation
The study team measured duration of breastfeeding and supplementation at day 3 postpartum and at specific timepoints through 3 months postpartum. Breastfeeding is defined as the feeding of human milk. The definition of "Exclusive Breastfeeding" is aligned with the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) and is as follows: the infant is fed only human milk and no other foods or fluids, not even water, except for oral rehydration solutions or drops/syrups of vitamins, minerals, or medicines. "Any Breastfeeding" is defined as the feeding of human milk supplemented with formula, water, etc. "Formula Only" is defined as the feeding of formula exclusively and no human milk.
Time frame: At day 3, week 6, and 3 months postpartum.
Enrollment
To assess recruitment and enrollment rates, the study team tracked the number of potential participants contacted/screened versus the number of participants who were eligible to enroll and the number of participants who consented to enroll in the study.
Time frame: This will occur between day 1 of the first participant screened to the study participant being randomized to one of two study arms.
mHealth Application Engagement
To assess intervention uptake, the study team tracked the number of calls engaging with the mobile health app and with the health coach.
Time frame: At 3 months postpartum.
mHealth Application Engagement (2)
To assess intervention uptake, the study team tracked the amount of time spent engaging with the mobile health app and with the health coach.
Time frame: At 3 months postpartum.
mHealth Application Usage
To assess intervention usage, the study team tracked logged tasks into the mobile health app.
Time frame: At 3 months postpartum.
| Milestone | DPP + Breastfeeding (Tx1) | Usual Care |
|---|---|---|
| Started | 22 | 21 |
| Completed | 17 | 20 |
| Not completed | 5 | 1 |
| Withdrew: Lost to follow-up | 4 | 1 |
| Withdrew: Adverse event | 1 | 0 |
The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms.
| lbs | DPP + Breastfeeding (Tx1) | Usual Care |
|---|---|---|
| Baseline - delivery (GWG) | 29.1 ± 20.4 | 36.0 ± 15.7 |
| Baseline - 3 months postpartum (weight retention) | 3.2 ± 16 | 11.0 ± 17.7 |
The study team measured maternal weight at baseline, at delivery, and at 3 months postpartum to allow for meaningful comparisons of weight change among study arms.
| lbs | DPP + Breastfeeding (Tx1) | Usual Care |
|---|---|---|
| Pre-pregnancy weight (self-reported) | 177.9 ± 26.5 | 179.2 ± 30.2 |
| Weight prior to delivery (per hospital record) | 206.1 ± 32.6 | 221.5 ± 30.5 |
| Weight at 3 months postpartum | 177.1 ± 25.4 | 191.1 ± 27.7 |
The study team measured duration of breastfeeding and supplementation at day 3 postpartum and at specific timepoints through 3 months postpartum. Breastfeeding is defined as the feeding of human milk. The definition of "Exclusive Breastfeeding" is aligned with the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) and is as follows: the infant is fed only human milk and no other foods or fluids, not even water, except for oral rehydration solutions or drops/syrups of vitamins, minerals, or medicines. "Any Breastfeeding" is defined as the feeding of human milk supplemented with formula, water, etc. "Formula Only" is defined as the feeding of formula exclusively and no human milk.
| Participants | DPP + Breastfeeding (Tx1) | Usual Care |
|---|---|---|
| 3 Days Postpartum — Exclusive breastfeeding | 13 | 12 |
| 3 Days Postpartum — Any breastfeeding | 2 | 3 |
| 3 Days Postpartum — Formula Only | 2 | 3 |
| 6 Weeks Postpartum — Exclusive breastfeeding | 10 | 12 |
| 6 Weeks Postpartum — Any breastfeeding | 3 | 4 |
| 6 Weeks Postpartum — Formula Only | 3 | 3 |
| 3 Months Postpartum — Exclusive breastfeeding | 9 | 11 |
| 3 Months Postpartum — Any breastfeeding | 3 | 5 |
| 3 Months Postpartum — Formula Only | 5 | 4 |
To assess recruitment and enrollment rates, the study team tracked the number of potential participants contacted/screened versus the number of participants who were eligible to enroll and the number of participants who consented to enroll in the study.
| participants | One Group: All Study Participants |
|---|---|
| Number Screened | 125 |
| Number Eligible of Screened | 73 |
| Number Consented of Screened | 43 |
To assess intervention uptake, the study team tracked the number of calls engaging with the mobile health app and with the health coach.
| attempts | DPP + Breastfeeding (Tx1) |
|---|---|
| Number of successful antepartum contact attempts with health coach | 8.4 ± 2.8 |
| Number of successful postpartum contact attempts with health coach | 9.2 ± 3.2 |
To assess intervention uptake, the study team tracked the amount of time spent engaging with the mobile health app and with the health coach.
| minutes | DPP + Breastfeeding (Tx1) |
|---|---|
| Length of antepartum call minutes with health coach | 10.3 ± 4 |
| Length of postpartum call minutes with health coach | 10.5 ± 5.1 |
To assess intervention usage, the study team tracked logged tasks into the mobile health app.
| logged tasks | DPP + Breastfeeding (Tx1) |
|---|---|
| Physical activities logged in mHealt app | 2 ± 6.1 |
| Meals logged in mHealth app | 19.6 ± 47.5 |
| Maternal weight logged in mHealth app | 7.1 ± 4.8 |
Collected over Adverse event data were collected from the time of enrollment through 3 months postpartum follow-up.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| DPP + Breastfeeding (Tx1) | 0/22 (0%) | 1/22 (4.5%) | 0/22 (0%) |
| Usual Care | 0/21 (0%) | 0/21 (0%) | 0/21 (0%) |
| Event | DPP + Breastfeeding (Tx1) | Usual Care |
|---|---|---|
| MiscarriagePregnancy, puerperium and perinatal conditions | 1/22 | 0/21 |
| Age, Continuous(Years) | DPP + Breastfeeding (Tx1) | Usual Care | Total |
|---|---|---|---|
| Mean | 31.7 ± 6.5 | 28.1 ± 5.5 | 30 ± 6.2 |
| Sex: Female, Male(Participants) | DPP + Breastfeeding (Tx1) | Usual Care | Total |
|---|---|---|---|
| Female | 22 | 21 | 43 |
| Male | 0 | 0 | 0 |
| Race/Ethnicity, Customized(Participants) | DPP + Breastfeeding (Tx1) | Usual Care | Total |
|---|---|---|---|
| Non-Hispanic White | 11 | 14 | 25 |
| Non-Hispanic Black | 4 | 0 | 4 |
| Non-Hispanic Asian | 1 | 0 | 1 |
| Hispanic | 6 | 7 | 13 |
| Highest Level of Education Completed(Participants) | DPP + Breastfeeding (Tx1) | Usual Care | Total |
|---|---|---|---|
| Graduated from high school | 4 | 3 | 7 |
| Some college | 3 | 7 | 10 |
| Graduated with an associate's degree | 2 | 0 | 2 |
| Graduated with a bachelor's degree | 5 | 7 | 12 |
| Advanced degree (e.g., Master's, PhD, MD, JD) | 8 | 4 | 12 |
| Location(Participants) | DPP + Breastfeeding (Tx1) | Usual Care | Total |
|---|---|---|---|
| Urban | 19 | 11 | 30 |
| Rural | 3 | 10 | 13 |
| Gross yearly total household income before taxes during the last 12 months(Participants) | DPP + Breastfeeding (Tx1) | Usual Care | Total |
|---|---|---|---|
| $9,999 or less | 2 | 3 | 5 |
| $10,000 to $24,999 | 0 | 1 | 1 |
| $25,000 to $49,999 | 7 | 8 | 15 |
| $50,000 to $74,999 | 0 | 4 | 4 |
| $75,000 to $99,999 | 5 | 0 | 5 |
| $100,000 or more | 8 | 5 | 13 |
| Currently have health insurance(Participants) | DPP + Breastfeeding (Tx1) | Usual Care | Total |
|---|---|---|---|
| Yes | 21 | 20 | 41 |
| No | 1 | 1 | 2 |
| WIC participation during pregnancy(Participants) | DPP + Breastfeeding (Tx1) | Usual Care | Total |
|---|---|---|---|
| Yes | 10 | 5 | 15 |
| No | 12 | 16 | 28 |
7 further baseline measures are reported on the registry.
PDFs hosted by the registry, ClinicalTrials.gov.
Ran from Apr 2024 to primary completion in Aug 2025, 16 months.
Results were first posted in Nov 2026, 1 year 2 months after primary completion.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 16 months is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Kansas Medical Center →